3-Year Safety Profile of Belatacept in Kidney Transplant Recipients from the BENEFIT and BENEFIT-EXT Studies

被引：0
|
作者：
Larsen, C. [1 ]
Grinyo, J. [2 ]
Pestana, J. M. [3 ]
Vanrenterghem, Y. [4 ]
Vincenti, F. [5 ]
Dong, Y. [6 ]
Thomas, D. [6 ]
Charpentier, B. [7 ]
机构：
[1] Emory Univ, Transplant Ctr, Atlanta, GA 30322 USA
[2] Univ Hosp Bellvitge, Barcelona, Spain
[3] Hosp Rim & Hipertensao, Sao Paulo, Brazil
[4] Katholieke Univ Leuven Hosp, Louvain, Belgium
[5] UCSF Kidney Transplant Serv, San Francisco, CA USA
[6] Bristol Myers Squibb Co, Princeton, NJ USA
[7] Hop Bicetre, Le Kremlin Bicetre, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
228
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [41] Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials
    Lange, Nicholas W.
    King, Kristen
    Husain, Syed Ali
    Salerno, David M.
    Tsapepas, Demetra S.
    Hedvat, Jessica
    Yu, Miko
    Mohan, Sumit
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (06) : 1027 - 1034
  • [42] A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
    Durrbach, A.
    Pestana, J. M.
    Pearson, T.
    Vincenti, F.
    Garcia, V. D.
    Campistol, J.
    del Carmen Rial, M.
    Florman, S.
    Block, A.
    Di Russo, G.
    Xing, J.
    Garg, P.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (03) : 547 - 557
  • [43] Outcomes at 3 Years in EBV plus European Subpopulations From BENEFIT and BENEFIT-EXT
    Blancho, G.
    Budde, K.
    Merville, P.
    Moal, M.
    Rostaing, L.
    Harler, M.
    Grinyo, J.
    TRANSPLANTATION, 2014, 98 : 455 - 455
  • [44] 5-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY
    Muehlbacher, Ferdinand
    Florman, Sander
    Zhang, Rubin
    Lang, Philippe
    Lehner, Frank
    Massari, Pablo
    Garcia, Valter D.
    Pupim, Lara
    Durrbach, Antoine
    TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
  • [45] Outcomes as a Function of Donor Criteria from a Phase III Study of Belatacept vs Cyclosporine in Kidney Transplantation (BENEFIT-EXT).
    Florman, Sander
    Durrbach, Antoine
    Larsen, Christian
    Pestana, Jose Medina
    Vanrenterghem, Yves
    Vincenti, Flavio
    Block, Alan
    Garg, Pushkal
    Copley, J. Brian
    Xing, Jun
    Grinyo, Josep
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 150 - 150
  • [46] Outcomes at 3 Years in EBV plus European Subpopulations From BENEFIT and BENEFIT-EXT
    Blancho, G.
    Budde, K.
    Merville, P.
    Moal, M.
    Rostaing, L.
    Harler, M.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 455 - 455
  • [47] OUTCOMES AT 3 YEARS IN EBV plus EUROPEAN SUBPOPULATIONS FROM BENEFIT AND BENEFIT-EXT
    Budde, K.
    Blancho, G.
    Merville, P.
    Moal, M. -C.
    Rostaing, L.
    Harler, M. B.
    Grinyo, J.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 33 - 33
  • [48] Five-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
    Durrbach, A.
    Florman, S.
    Zhang, R.
    Lang, P.
    Lehner, F.
    Massari, P.
    Garcia, V.
    Pupim, L.
    Muehlbacher, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 311
  • [49] Belatacept Is Associated with Preservation of Renal Function and Structure at 1 Year Compared to Cyclosporine in Extended Criteria Donor (ECD) Kidney Transplant Patients (BENEFIT-EXT Study).
    Medina-Pestana, J. D.
    Campistol, J. M.
    Rial, M. del C.
    Garcia, V. D.
    Becker, T.
    Agarwal, M.
    Garg, P.
    Duan, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 199 - 199
  • [50] BELATACEPT IS ASSOCIATED WITH PRESERVATION OF RENAL FUNCTION AND STRUCTURE AT 1 YEAR COMPARED TO CYCLOSPORINE IN EXTENDED CRITERIA DONOR (ECD) KIDNEY TRANSPLANT PATIENTS (BENEFIT-EXT STUDY)
    Medina-Pestana, J. D.
    Campistol, J. M.
    Rial, M. del C.
    Garcia, V. D.
    Becker, T.
    Agarwal, M.
    Garg, P.
    Duan, T.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 89 - 89
12345